Table 1

Antenatal and perinatal characteristics and major neonatal morbidities among infants followed-up and lost to follow-up

CharacteristicLost to follow-up (n=497)Followed-up (n=1473)p Value
Maternal age, years27.0 (22.0–32.0)30.0 (26.0–34.0)<0.01
Aboriginal ethnicity35 (7.0)21 (1.4)<0.01
Primipara129 (26.0)489 (33.2)<0.01
Assisted conception34 (6.8)217 (14.7)<0.01
Multiple pregnancy114 (22.9)392 (26.6)0.12
Pregnancy induced hypertension50 (10.1)261 (17.7)<0.01
Ante-partum haemorrhage170 (34.2)439 (29.8)0.08
Gestational diabetes5 (1.0)33 (2.2)0.12
Any antenatal corticosteroid429 (86.3)1323 (89.8)0.04
Chorioamnionitis*73/327 (22.3)164/764 (21.4)0.80
Vaginal breech41 (8.2)149 (10.1)0.26
Caesarean section in labour128 (25.8)339 (23.0)0.23
Born in non-tertiary centre82 (16.5)109 (7.4)<0.01
Apgar score <7 at 5 min86 (17.3)282 (19.1)0.41
Male gender261 (52.5)787 (53.4)0.76
Gestational age, weeks27.0 (26.0–28.0)27.0 (26.0–28.0)1.00
Birth weight , grams1029.0 (866.5–1187.5)945.0 (776.0–1110.0)<0.01
Birth weight <10th percentile26 (5.2)152 (10.2)<0.01
Head circumference, cm25.5 (24.0–26.5)24.3 (23.3–26.0)<0.01
Head circumference <10th percentile25 (5.0)118 (8.0)0.02
Admitted after office hours326 (65.6)972 (66.0)0.92
Surfactant therapy299 (60.2)1051 (71.4)<0.01
Mechanical ventilation384 (77.3)1286 (87.3)<0.01
Duration of ventilation, days4.6 (2.0–14.34)7.9 (3.0–21.1)<0.01
PDA requiring treatment190 (38.2)647 (43.9)0.03
Proven systemic infection141 (28.4)595 (40.4)<0.01
IVH grade 3 or 4†22/496 (4.4)93/1472 (6.3)0.16
Necrotising entercolitis18 (3.6)56 (3.8)0.95
Chronic lung disease133 (26.8)596 (40.5)<0.01
Post-natal steroid for CLD78 (15.7)408 (27.7)<0.01
Home oxygen58 (11.7)306 (20.8)<0.01
ROP grade 3 or 4†36/481 (7.5)187/1456 (12.8)<0.01
Length of NICU stay, days74.0 (63.0–93.0)82.0 (69.0–102.0)<0.01
  • Data are presented as n (%) or median (IQR). Followed-up group was set as a referent for OR and 95% CI calculation.

  • *Chorioamnionitis including clinically suspected cases. Data collected from 2001 onwards. Denominator is number of total followed-up from 2001 onwards.

  • †Denominator is number of infants examined.

  • CLD, chronic lung disease; IVH, intraventricular haemorrhage; NICU, neonatal intensive care unit; PDA, patent ductus arteriosus; ROP, retinopathy of prematurity.